Molecular Mechanisms Underlying the Loop-Closing Dynamics of β-1,4 Galactosyltransferase 1
- PMID: 39737871
- PMCID: PMC11734692
- DOI: 10.1021/acs.jcim.4c02010
Molecular Mechanisms Underlying the Loop-Closing Dynamics of β-1,4 Galactosyltransferase 1
Abstract
The β-1,4 galactosylation catalyzed by β-1,4 galactosyltransferases (β4Gal-Ts) is not only closely associated with diverse physiological and pathological processes in humans but also widely applied in the N-glycan modification of protein glycoengineering. The loop-closing process of β4Gal-Ts is an essential intermediate step intervening in the binding events of donor substrate (UDP-Gal/Mn2+) and acceptor substrate during its catalytic cycle, with a significant impact on the galactosylation activities. However, the molecular mechanisms in regulating loop-closing dynamics are not entirely clear. Here, we construct Markov state models (MSMs) based on approximately 20 μs of all-atom molecular dynamics simulations to explore the loop-closing dynamics for β-1,4 galactosyltransferase 1 (β4Gal-T1). Our MSM reveals five key metastable states of β4Gal-T1 upon substrate binding, indicating that the entire conformational transition occurs on a time scale of ∼10 μs. Moreover, a regulatory mechanism involving six conserved residues (R187, H190, F222, W310, I341, and D346) among β4Gal-Ts is validated to account for the loop-closing dynamics of the C-loop and W-loop by site-directed mutagenesis and enzymatic activity assays, exhibiting high consistency with our computational predictions. Overall, our research proposes detailed atomic-level insight into the loop-closing dynamics of the C-loop and W-loop on β4Gal-T1, contributing to a deeper understanding of catalytic mechanisms of β-1,4 galactosylation.
Conflict of interest statement
The authors declare no competing financial interest.
Similar articles
-
Oligosaccharide preferences of beta1,4-galactosyltransferase-I: crystal structures of Met340His mutant of human beta1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety.J Mol Biol. 2005 Oct 14;353(1):53-67. doi: 10.1016/j.jmb.2005.07.050. J Mol Biol. 2005. PMID: 16157350
-
Cloning and expression of a proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I. A seventh member of the human beta4-galactosyltransferase gene family.J Biol Chem. 1999 Sep 10;274(37):26165-71. doi: 10.1074/jbc.274.37.26165. J Biol Chem. 1999. PMID: 10473568
-
The role of tryptophan 314 in the conformational changes of beta1,4-galactosyltransferase-I.J Mol Biol. 2003 Aug 29;331(5):1065-76. doi: 10.1016/s0022-2836(03)00790-3. J Mol Biol. 2003. PMID: 12927542
-
Structure and function of beta -1,4-galactosyltransferase.Curr Drug Targets. 2008 Apr;9(4):292-309. doi: 10.2174/138945008783954943. Curr Drug Targets. 2008. PMID: 18393823 Free PMC article. Review.
-
Markov state models provide insights into dynamic modulation of protein function.Acc Chem Res. 2015 Feb 17;48(2):414-22. doi: 10.1021/ar5002999. Epub 2015 Jan 3. Acc Chem Res. 2015. PMID: 25625937 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources